Market Cap | 2.69B | P/E | - | EPS this Y | -19.70% | Ern Qtrly Grth | - |
Income | -40.12M | Forward P/E | -65.40 | EPS next Y | 21.50% | 50D Avg Chg | 13.00% |
Sales | 429.95M | PEG | -1.80 | EPS past 5Y | - | 200D Avg Chg | 28.00% |
Dividend | N/A | Price/Book | 5.83 | EPS next 5Y | 20.00% | 52W High Chg | -5.00% |
Recommedations | 1.70 | Quick Ratio | 2.77 | Shares Outstanding | 48.70M | 52W Low Chg | 75.00% |
Insider Own | 3.19% | ROA | -3.65% | Shares Float | 47.04M | Beta | 1.44 |
Inst Own | 106.19% | ROE | -8.68% | Shares Shorted/Prior | 3.55M/3.64M | Price | 56.90 |
Gross Margin | 74.84% | Profit Margin | -9.33% | Avg. Volume | 291,016 | Target Price | 41.13 |
Oper. Margin | -6.17% | Earnings Date | Oct 30 | Volume | 376,693 | Change | 1.16% |
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
BTIG | Buy | Jul 31, 24 |
JP Morgan | Overweight | Jul 31, 24 |
Stifel | Buy | Jul 31, 24 |
Needham | Buy | Jul 31, 24 |
Piper Sandler | Overweight | Jul 31, 24 |
Needham | Buy | Jul 8, 24 |
Canaccord Genuity | Buy | May 2, 24 |
JP Morgan | Overweight | May 2, 24 |
Needham | Buy | May 2, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Dahlquist Karl S. | Chief Legal Officer Chief Legal Officer | Nov 01 | Sell | 34.43 | 1,248 | 42,969 | 30,789 | 11/03/23 |
Dahlquist Karl S. | Chief Legal Officer Chief Legal Officer | Jul 26 | Sell | 57.09 | 3,417 | 195,077 | 32,037 | 07/28/23 |
Prange Karen | Director Director | Jun 08 | Sell | 47.89 | 713 | 34,146 | 16,140 | 06/12/23 |
Dahlquist Karl S. | Chief Legal Officer Chief Legal Officer | Jun 06 | Sell | 47.03 | 1,422 | 66,877 | 34,897 | 06/07/23 |
Yuen Maggie | Director Director | May 26 | Sell | 47.04 | 4,313 | 202,884 | 4,682 | 05/30/23 |
Collar Mark A | Director Director | Mar 13 | Option | 9.30 | 10,000 | 93,000 | 100,871 | 03/15/23 |
WHITE ROBERT S. | Director Director | Aug 31 | Option | 8.48 | 15,000 | 127,200 | 55,799 | 09/02/22 |
Austin Tonya | Chief Human Resource.. Chief Human Resources Officer | May 13 | Sell | 42.69 | 3,203 | 136,736 | 17,621 | 05/17/22 |
Austin Tonya | Chief Human Resource.. Chief Human Resources Officer | Apr 08 | Sell | 61.59 | 282 | 17,368 | 20,824 | 04/12/22 |
Collar Mark A | Director Director | Mar 16 | Option | 8.40 | 10,000 | 84,000 | 87,307 | 03/18/22 |
WHITE ROBERT S. | Director Director | Mar 03 | Option | 8.48 | 15,000 | 127,200 | 37,235 | 03/07/22 |
Austin Tonya | Chief Human Resource.. Chief Human Resources Officer | Mar 04 | Sell | 67.66 | 1,409 | 95,333 | 21,106 | 03/07/22 |
Austin Tonya | Chief Human Resource.. Chief Human Resources Officer | Mar 02 | Sell | 69.86 | 4,885 | 341,266 | 22,515 | 03/04/22 |
Austin Tonya | Chief Human Resource.. Chief Human Resources Officer | Feb 11 | Sell | 67.97 | 2,490 | 169,245 | 20,340 | 02/15/22 |
Austin Tonya | Chief Human Resource.. Chief Human Resources Officer | Jan 14 | Sell | 66.11 | 2,719 | 179,753 | 22,830 | 01/18/22 |
WEHRWEIN SVEN | Director Director | May 05 | Option | 19.95 | 5,000 | 99,750 | 17,686 | 05/05/21 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Feb 04 | Option | 21.04 | 25,000 | 526,000 | 529,795 | 02/04/21 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Feb 04 | Sell | 60 | 25,000 | 1,500,000 | 504,795 | 02/04/21 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Jan 13 | Option | 21.04 | 25,000 | 526,000 | 529,795 | 01/13/21 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Jan 13 | Sell | 59 | 25,000 | 1,475,000 | 504,795 | 01/13/21 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Dec 28 | Option | 21.04 | 25,000 | 526,000 | 529,457 | 12/28/20 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Dec 28 | Sell | 58 | 25,000 | 1,450,000 | 504,504 | 12/28/20 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Dec 23 | Option | 21.04 | 74,751 | 1,572,761 | 529,504 | 12/23/20 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Dec 23 | Sell | 56 | 74,751 | 4,186,056 | 504,504 | 12/23/20 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Dec 21 | Option | 13.48 | 125,249 | 1,688,357 | 554,753 | 12/21/20 |
CARREL MICHAEL H | President, CEO, & Di.. President, CEO, & Director | Dec 21 | Sell | 51.63 | 125,249 | 6,466,606 | 504,504 | 12/21/20 |